Jong-Hyuk Ahn
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Jong-Hyuk Ahn has a total of 91 co-authors. Here are the top co-authors by number of shared publications:
- Jin Wook Yi
Department of Surgery, Inha University Hospital, Inha University College of Medicine, Incheon, Korea
11 shared publications - Bo Hyun Kim
Department of Internal Medicine, Pusan National University Hospital, Busan, Korea
4 shared publications - Bon Seok Koo
Department of Otolaryngology-Head and Neck Surgery, College of Medicine, Chungnam National University, Daejeon 35015, Republic of Korea
4 shared publications - Dong Gyu Na
Department of Radiology, Gangneung Asan Hospital, University of Ulsan College of Medicine, Gangneung, Korea
4 shared publications - Dong-Jun Lim
Department of Internal Medicine, Seoul St. Mary’s Hospital, College of Medicine, the Catholic University of Korea, Seoul, Korea
4 shared publications - Eun Kyung Lee
Department of Internal Medicine, National Cancer Center, Goyang, Republic of Korea
4 shared publications
Latest Publications
- Open Access
- 31 August 2026
- Published by Korean Endocrine Society in Endocrinology and Metabolism
- Vol. 41 (4) , 493-534
Korean Thyroid Association Guidelines on the Management of Differentiated Thyroid Cancers, Part II: Follow-up Surveillance after Initial Treatment 2026
In patients with differentiated thyroid cancer, initial recurrence-risk stratification based on clinical, histopathological, and perioperative findings remains central to management during the first 1–2 years after initial treatment. Ongoing risk stratification (ORS) complements this initial assessment by continuously integrating longitudinal clinical data and treatment response, thereby refining long-term prognostic assessment and supporting individualized risk-adapted management. Building on the 2024 Korean Thyroid Association (KTA) guidelines, the 2026 KTA guideline incorporates new evidence from large Korean multicenter cohorts and comprehensive systematic reviews. The updated recommendations reinforce the continued application of ORS and provide more specific guidance on risk-adapted thyroid-stimulating hormone (TSH) targets, surveillance strategies for recurrence detection, and long-term follow-up tailored to individual recurrence risk and treatment response. Consistent with the evolving paradigm toward risk-adapted and individualized management, this revision updates recommendations regarding target serum TSH levels, serum thyroglobulin thresholds for response assessment and long-term surveillance, and follow-up intervals based on both initial-risk category and the ORS response category. These evidence-based recommendations aim to minimize unnecessary treatment and excessive surveillance in the majority of patients who have an excellent prognosis after initial therapy while ensuring individualized long-term management for patients who require closer surveillance or additional therapeutic intervention.
- 31 August 2026
- Published by Korean Endocrine Society in Endocrinology and Metabolism
- Vol. 41 (4) , 493-534
Open AccessKorean Thyroid Association Guidelines on the Management of Differentiated Thyroid Cancers, Part II: Follow-up Surveillance after Initial Treatment 2026
In patients with differentiated thyroid cancer, initial recurrence-risk stratification based on clinical, histopathological, and perioperative findings remains central to management during the first 1–2 years after initial treatment. Ongoing risk stratification (ORS) complements this initial assessment by continuously integrating longitudinal clinical data and treatment response, thereby refining long-term prognostic assessment and supporting individualized risk-adapted management. Building on the 2024 Korean Thyroid Association (KTA) guidelines, the 2026 KTA guideline incorporates new evidence from large Korean multicenter cohorts and comprehensive systematic reviews. The updated recommendations reinforce the continued application of ORS and provide more specific guidance on risk-adapted thyroid-stimulating hormone (TSH) targets, surveillance strategies for recurrence detection, and long-term follow-up tailored to individual recurrence risk and treatment response. Consistent with the evolving paradigm toward risk-adapted and individualized management, this revision updates recommendations regarding target serum TSH levels, serum thyroglobulin thresholds for response assessment and long-term surveillance, and follow-up intervals based on both initial-risk category and the ORS response category. These evidence-based recommendations aim to minimize unnecessary treatment and excessive surveillance in the majority of patients who have an excellent prognosis after initial therapy while ensuring individualized long-term management for patients who require closer surveillance or additional therapeutic intervention.
- Open Access
- 30 May 2026
- Published by Korean Thyroid Association in International Journal of Thyroidology
- Vol. 19 (1) , 1-40
Korean Thyroid Association Guidelines on the Management of Differentiated Thyroid Cancers; Part II. Follow-up Surveillance after Initial Treatment 2026
Eun Kyung Lee, Seung Heon Kang, Bon Seok Koo, Mijin Kim, Min Joo Kim, Bo Hyun Kim, Ji Won Kim, Dong Gyu Na, Sohyun Park, Ji-In Bang, Kyorim Back, Youngduk Seo, Young-Ik Son, Young Shin Song, Dong Yeob Shin, Jong-Hyuk Ahn, Hwa Young Ahn, So Won Oh, Ho-Ryun Won, Won Sang Yoo, Min Kyoung Lee, Sang-Woo Lee, Jeongmin Lee, Ji Ye Lee, Dong-Jun Lim, Ki-Wook Chung, Ari Chong, Jin Hyang Jung, Sun Wook Cho, Yoon Young Cho, Chae Moon Hong, Young Joo Park and Korean Thyroid Association Guideline Committee on the Management of Thyroid Nodule and Cancer. Int J Thyroidol 2026;19:1-40. https://doi.org/10.11106/ijt.2026.19.1.1
- 30 May 2026
- Published by Korean Thyroid Association in International Journal of Thyroidology
- Vol. 19 (1) , 1-40
Open AccessKorean Thyroid Association Guidelines on the Management of Differentiated Thyroid Cancers; Part II. Follow-up Surveillance after Initial Treatment 2026
Eun Kyung Lee, Seung Heon Kang, Bon Seok Koo, Mijin Kim, Min Joo Kim, Bo Hyun Kim, Ji Won Kim, Dong Gyu Na, Sohyun Park, Ji-In Bang, Kyorim Back, Youngduk Seo, Young-Ik Son, Young Shin Song, Dong Yeob Shin, Jong-Hyuk Ahn, Hwa Young Ahn, So Won Oh, Ho-Ryun Won, Won Sang Yoo, Min Kyoung Lee, Sang-Woo Lee, Jeongmin Lee, Ji Ye Lee, Dong-Jun Lim, Ki-Wook Chung, Ari Chong, Jin Hyang Jung, Sun Wook Cho, Yoon Young Cho, Chae Moon Hong, Young Joo Park and Korean Thyroid Association Guideline Committee on the Management of Thyroid Nodule and Cancer. Int J Thyroidol 2026;19:1-40. https://doi.org/10.11106/ijt.2026.19.1.1
- 2 January 2026
- Published by Springer Nature
- p. 142-151
XTag-CLIP: Robust and Reliable Thyroid Scar Analysis with Limited Data via Cross-Attention
- 2 January 2026
- Published by Springer Nature
- p. 142-151
XTag-CLIP: Robust and Reliable Thyroid Scar Analysis with Limited Data via Cross-Attention
- Open Access
- 1 January 2026
- Published by XMLink in Journal of Endocrine Surgery
- Vol. 26 (1) , 21-30
Single Areolar Robotic Approach for Thyroidectomy and Parathyroidectomy Without Additional Ports: A Feasibility Case Series
Ahn JH. J Endocr Surg. 2026 Mar;26(1):21-30. https://doi.org/10.16956/jes.2026.26.1.21
- 1 January 2026
- Published by XMLink in Journal of Endocrine Surgery
- Vol. 26 (1) , 21-30
Open AccessSingle Areolar Robotic Approach for Thyroidectomy and Parathyroidectomy Without Additional Ports: A Feasibility Case Series
Ahn JH. J Endocr Surg. 2026 Mar;26(1):21-30. https://doi.org/10.16956/jes.2026.26.1.21
- Open Access
- 30 June 2025
- Published by Korean Endocrine Society in Endocrinology and Metabolism
- Vol. 40 (3) , 307-341
2025 Korean Thyroid Association Clinical Management Guideline on Active Surveillance for Low-Risk Papillary Thyroid Carcinoma
The increasing detection of papillary thyroid microcarcinoma (PTMC) has raised concerns regarding overtreatment. For low-risk PTMC, either immediate surgery or active surveillance (AS) can be considered. To facilitate the implementation of AS, the Korean Thyroid Association convened a multidisciplinary panel and developed the first Korean guideline. AS is recommended for adults with pathologically confirmed Bethesda V–VI PTMC who have no clinical evidence of lymph node or distant metastasis, gross extrathyroidal extension, invasion of the trachea or recurrent laryngeal nerve, or aggressive histology. A baseline assessment requires high-resolution neck ultrasound performed by experienced operators to exclude extrathyroidal extension, tracheal or recurrent laryngeal nerve invasion, and lymph node metastasis; contrast-enhanced neck computed tomography is optional. Patient characteristics, including age, comorbidities, and the capacity for long-term follow-up, should be thoroughly assessed. Shared decision-making should carefully weigh the benefits and risks of surgery versus AS, considering expected oncologic outcomes, potential complications, quality of life, anxiety, medical costs, and patient preference. Follow-up involves neck ultrasound and thyroid function tests every 6 months for 2 years and annually thereafter. Disease progression, defined as significant tumor growth or newly detected nodal or distant metastasis, warrants surgery. Despite remaining uncertainties, this guideline provides a structured framework to ensure oncologic safety and supports patient-centered AS.
- 30 June 2025
- Published by Korean Endocrine Society in Endocrinology and Metabolism
- Vol. 40 (3) , 307-341
Open Access2025 Korean Thyroid Association Clinical Management Guideline on Active Surveillance for Low-Risk Papillary Thyroid Carcinoma
The increasing detection of papillary thyroid microcarcinoma (PTMC) has raised concerns regarding overtreatment. For low-risk PTMC, either immediate surgery or active surveillance (AS) can be considered. To facilitate the implementation of AS, the Korean Thyroid Association convened a multidisciplinary panel and developed the first Korean guideline. AS is recommended for adults with pathologically confirmed Bethesda V–VI PTMC who have no clinical evidence of lymph node or distant metastasis, gross extrathyroidal extension, invasion of the trachea or recurrent laryngeal nerve, or aggressive histology. A baseline assessment requires high-resolution neck ultrasound performed by experienced operators to exclude extrathyroidal extension, tracheal or recurrent laryngeal nerve invasion, and lymph node metastasis; contrast-enhanced neck computed tomography is optional. Patient characteristics, including age, comorbidities, and the capacity for long-term follow-up, should be thoroughly assessed. Shared decision-making should carefully weigh the benefits and risks of surgery versus AS, considering expected oncologic outcomes, potential complications, quality of life, anxiety, medical costs, and patient preference. Follow-up involves neck ultrasound and thyroid function tests every 6 months for 2 years and annually thereafter. Disease progression, defined as significant tumor growth or newly detected nodal or distant metastasis, warrants surgery. Despite remaining uncertainties, this guideline provides a structured framework to ensure oncologic safety and supports patient-centered AS.
- 9 June 2025
- Published by Springer Nature in Updates in Surgery
- Vol. 78 (1) , 327-342
DNA methylation changes in thyroid cancer patients infected with SARS-CoV-2
The impact of SARS-CoV-2 infection on thyroid cancer at the genomic level remains poorly understood. The purpose of our study was to determine whether significant DNA methylation changes occur in thyroid cancer tissues from patients with recent SARS-CoV-2 infection. Surgically resected normal thyroid and Papillary (PTC) tissues from three COVID-19-infected PTC patients (Cases) and three prepandemic PTC patients (Controls) were analyzed using DNA methylation EPIC arrays. Differentially methylated probes (DMPs) and differentially methylated regions (DMRs) were identified in normal thyroid and PTC tissues. Functional enrichment analysis was subsequently performed to explore the affected pathways. COVID-19-infected PTC tissues presented distinct DNA methylation profiles, with 6,848 DMPs in PTC tissues compared with 140 in normal thyroid tissues. SARS-CoV-2 infection did not significantly affect normal thyroid tissue by methylation. SARS-CoV-2 infection in PTC tissues was associated with hypermethylation of tumor suppressor genes (RUNX3, PAOX), the Wnt signaling pathway, the HOX gene family, cell adhesion-related genes and hypomethylation in response to virus-related genes. The key DMRs identified in PTC included GPR75, CCDC80, and ENTPD3, suggesting altered cell adhesion, tumor proliferation, and immune evasion. SARS-CoV-2 infection is linked to significant DNA methylation alterations in PTC tissues, with potential implications for tumor progression and aggressiveness. These findings suggest that COVID-19 may influence thyroid cancer biology. Further research is needed to validate these epigenetic modifications, establish causal relationships and determine their clinical relevance.
- 9 June 2025
- Published by Springer Nature in Updates in Surgery
- Vol. 78 (1) , 327-342
DNA methylation changes in thyroid cancer patients infected with SARS-CoV-2
The impact of SARS-CoV-2 infection on thyroid cancer at the genomic level remains poorly understood. The purpose of our study was to determine whether significant DNA methylation changes occur in thyroid cancer tissues from patients with recent SARS-CoV-2 infection. Surgically resected normal thyroid and Papillary (PTC) tissues from three COVID-19-infected PTC patients (Cases) and three prepandemic PTC patients (Controls) were analyzed using DNA methylation EPIC arrays. Differentially methylated probes (DMPs) and differentially methylated regions (DMRs) were identified in normal thyroid and PTC tissues. Functional enrichment analysis was subsequently performed to explore the affected pathways. COVID-19-infected PTC tissues presented distinct DNA methylation profiles, with 6,848 DMPs in PTC tissues compared with 140 in normal thyroid tissues. SARS-CoV-2 infection did not significantly affect normal thyroid tissue by methylation. SARS-CoV-2 infection in PTC tissues was associated with hypermethylation of tumor suppressor genes (RUNX3, PAOX), the Wnt signaling pathway, the HOX gene family, cell adhesion-related genes and hypomethylation in response to virus-related genes. The key DMRs identified in PTC included GPR75, CCDC80, and ENTPD3, suggesting altered cell adhesion, tumor proliferation, and immune evasion. SARS-CoV-2 infection is linked to significant DNA methylation alterations in PTC tissues, with potential implications for tumor progression and aggressiveness. These findings suggest that COVID-19 may influence thyroid cancer biology. Further research is needed to validate these epigenetic modifications, establish causal relationships and determine their clinical relevance.
- Open Access
- 30 May 2025
- Published by Korean Thyroid Association in International Journal of Thyroidology
- Vol. 18 (1) , 30-64
2025 Korean Thyroid Association Clinical Management Guideline on Active Surveillance for Low-Risk Papillary Thyroid Carcinoma
Eun Kyung Lee, Min Joo Kim, Seung Heon Kang, Bon Seok Koo, Kyungsik Kim, Mijin Kim, Bo Hyun Kim, Ji-hoon Kim, Shin Je Moon, Kyorim Back, Young Shin Song, Jong-hyuk Ahn, Hwa Young Ahn, Ho-Ryun Won, Won Sang Yoo, Min Kyoung Lee, Jeongmin Lee, Ji Ye Lee, Kyong Yeun Jung, Chan Kwon Jung, Yoon Young Cho, Dong-Jun Lim, Sun Wook Kim, Young Joo Park, Dong Gyu Na and Jee Soo Kim. Int J Thyroidol 2025;18:30-64. https://doi.org/10.11106/ijt.2025.18.1.30
- 30 May 2025
- Published by Korean Thyroid Association in International Journal of Thyroidology
- Vol. 18 (1) , 30-64
Open Access2025 Korean Thyroid Association Clinical Management Guideline on Active Surveillance for Low-Risk Papillary Thyroid Carcinoma
Eun Kyung Lee, Min Joo Kim, Seung Heon Kang, Bon Seok Koo, Kyungsik Kim, Mijin Kim, Bo Hyun Kim, Ji-hoon Kim, Shin Je Moon, Kyorim Back, Young Shin Song, Jong-hyuk Ahn, Hwa Young Ahn, Ho-Ryun Won, Won Sang Yoo, Min Kyoung Lee, Jeongmin Lee, Ji Ye Lee, Kyong Yeun Jung, Chan Kwon Jung, Yoon Young Cho, Dong-Jun Lim, Sun Wook Kim, Young Joo Park, Dong Gyu Na and Jee Soo Kim. Int J Thyroidol 2025;18:30-64. https://doi.org/10.11106/ijt.2025.18.1.30
- Open Access
- 1 May 2025
- Published by SAGE Publications in Digital Health
- Vol. 11
Feasibility and initial clinical application of a digital health–enabled 3D VR education model to improve health literacy in thyroid surgery
Objectives: Effective physician–patient communication is essential for improving health literacy and achieving optimal surgical outcomes. However, patients often struggle to interpret conventional two-dimensional (2D) imaging during preoperative counseling for thyroid surgery. This study assessed the feasibility of a ray-traced three-dimensional (3D) virtual reality (VR) educational model to enhance patient health literacy and satisfaction. Methods: A patient-specific ray-traced 3D VR educational model was developed using deep learning–based multi-organ segmentation of CT scans and rendered on flat monitors commonly available in outpatient clinics. A structured two-round counseling protocol was conducted: in the first round, conventional 2D CT images were used, and in the second round, the 3D VR model was presented. After counseling, patients completed a survey assessing comprehension and satisfaction by comparing the 3D VR educational model with 2D CT images. Results: All patients reported improved understanding of their condition after viewing the 3D VR educational model. Most participants (88.9%) expressed high satisfaction and willingness to use the model in future consultations. Conclusions: Ray-traced 3D VR educational models are feasible for improving patient health literacy during preoperative counseling. This digital technology–based approach offers a practical and scalable tool to support more informed, meaningful discussions and enhance patient understanding.
- 1 May 2025
- Published by SAGE Publications in Digital Health
- Vol. 11
Open AccessFeasibility and initial clinical application of a digital health–enabled 3D VR education model to improve health literacy in thyroid surgery
Objectives: Effective physician–patient communication is essential for improving health literacy and achieving optimal surgical outcomes. However, patients often struggle to interpret conventional two-dimensional (2D) imaging during preoperative counseling for thyroid surgery. This study assessed the feasibility of a ray-traced three-dimensional (3D) virtual reality (VR) educational model to enhance patient health literacy and satisfaction. Methods: A patient-specific ray-traced 3D VR educational model was developed using deep learning–based multi-organ segmentation of CT scans and rendered on flat monitors commonly available in outpatient clinics. A structured two-round counseling protocol was conducted: in the first round, conventional 2D CT images were used, and in the second round, the 3D VR model was presented. After counseling, patients completed a survey assessing comprehension and satisfaction by comparing the 3D VR educational model with 2D CT images. Results: All patients reported improved understanding of their condition after viewing the 3D VR educational model. Most participants (88.9%) expressed high satisfaction and willingness to use the model in future consultations. Conclusions: Ray-traced 3D VR educational models are feasible for improving patient health literacy during preoperative counseling. This digital technology–based approach offers a practical and scalable tool to support more informed, meaningful discussions and enhance patient understanding.
- Open Access
- 15 January 2024
- Published by Springer Nature in npj Microgravity
- Vol. 10 (1) , 1-14
Morphologic and genomic changes of thyroid cancer cell lines exposed to conditions of simulated microgravity
Microgravity in space impacts human health. In particular, thyroid cancer, which has a high incidence rate, has been the subject of numerous studies with respect to microgravity. However, most studies have focused on Western follicular thyroid cancer cell lines, while data regarding the effects of microgravity on Asian cell lines are lacking. Therefore, we aimed to investigate the effect of simulated ground-based microgravity on two Korean thyroid cancer cell lines, namely SNU-790 and SNU-80. We found that both cell lines formed multicellular spheroids under simulated microgravity. Gene expression analysis revealed that in SNU-790 cells, histone-related genes were upregulated and microRNA-related genes were downregulated. Meanwhile, in SNU-80 cells, genes related to the cellular response to hypoxia were downregulated. These findings contribute to a better understanding of the effects of microgravity on thyroid cancer cells. Further validation studies and clinical significance analyses are needed to fully understand the implications of these findings.
- 15 January 2024
- Published by Springer Nature in npj Microgravity
- Vol. 10 (1) , 1-14
Open AccessMorphologic and genomic changes of thyroid cancer cell lines exposed to conditions of simulated microgravity
Microgravity in space impacts human health. In particular, thyroid cancer, which has a high incidence rate, has been the subject of numerous studies with respect to microgravity. However, most studies have focused on Western follicular thyroid cancer cell lines, while data regarding the effects of microgravity on Asian cell lines are lacking. Therefore, we aimed to investigate the effect of simulated ground-based microgravity on two Korean thyroid cancer cell lines, namely SNU-790 and SNU-80. We found that both cell lines formed multicellular spheroids under simulated microgravity. Gene expression analysis revealed that in SNU-790 cells, histone-related genes were upregulated and microRNA-related genes were downregulated. Meanwhile, in SNU-80 cells, genes related to the cellular response to hypoxia were downregulated. These findings contribute to a better understanding of the effects of microgravity on thyroid cancer cells. Further validation studies and clinical significance analyses are needed to fully understand the implications of these findings.
- Open Access
- 25 October 2023
- Published by Elsevier in Asian Journal of Surgery
- Vol. 47 (1) , 360-366
Intraoperative pathologic evaluation of central compartment lymph nodes in patients undergoing lobectomy for unilateral papillary thyroid carcinoma
- 25 October 2023
- Published by Elsevier in Asian Journal of Surgery
- Vol. 47 (1) , 360-366
Open AccessIntraoperative pathologic evaluation of central compartment lymph nodes in patients undergoing lobectomy for unilateral papillary thyroid carcinoma